Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

685 public trials 115 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Active, Not Recruiting

Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

NCT06234488

Conditions
Breast Adenocarcinoma, Breast Cancer, Breast Cancer Invasive, +14 more
Locations
  • University of Southern California/Los Angeles (USC/LA County) Los Angeles, California, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
  • University of Colorado Anschutz Medical Campus (CU Anschutz) Aurora, Colorado, United States
  • MedStar Georgetown University Hospital (MGUH) Washington D.C., District of Columbia, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer

NCT01723774

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Mayo Clinic - Scottsdale Scottsdale, Arizona, United States
  • Mayo Clinic - Rochester Rochester, Minnesota, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

NCT04561362

Conditions
Adnexal Diseases, Advanced Solid Tumor, Breast Diseases, +30 more
Locations
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Ocala Oncology Center Ocala, Florida, United States
  • Advent Health Orlando, Florida, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer

NCT02107703

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • St. Bernards Medical Center Jonesboro, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University of California - San Diego La Jolla, California, United States
  • Kaiser Permanente Riverside, California, United States
View all 146 locations
View Trial Details
Active, Not Recruiting

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

NCT04557449

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Breast Diseases, +33 more
Locations
  • Ellison Institute Los Angeles, California, United States
  • Smilow Cancer Hospital at Yale - New Haven New Haven, Connecticut, United States
  • Yale-New Haven Hospital-Yale Cancer Center New Haven, Connecticut, United States
  • Smilow Cancer Hospital Phase 1 Unit New Haven, Connecticut, United States
View all 38 locations
View Trial Details
Active, Not Recruiting

Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.

NCT03283384

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands
  • Ziekenhuisgroep Twente Almelo, Netherlands
  • Ziekenhuis Amstelland Amstelveen, Netherlands
  • Nederlands Kanker Instituut - Antoni van Leeuwenhoek Amsterdam, Netherlands
View all 29 locations
View Trial Details
Active, Not Recruiting

Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast Cancer

NCT03904173

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Haukeland University Hospital Bergen, Norway
  • Drammen Hospital - Vestre Viken Drammen, Buskerud, Norway
  • Østfold Hospital Sarpsborg, Kalnes, Norway
  • Oslo University Hospital Oslo, Norway
View Trial Details

Related conditions